Primary vitreoretinal lymphoma: a diagnostic and management challenge.
Soussain C, Malaise D, Cassoux N.
Blood. 2021 Oct 28;138(17):1519-1534. doi: 10.1182/blood.2020008235.
The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal Lymphoma.
Stacey AW, Pulido JS.
Retina. 2020 Jul;40(7):1213-1214. doi: 10.1097/IAE.0000000000002851.
Patient-derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma.
Isbell LK, Tschuch C, Doostkam S, Waldeck S, Andrieux G, Shoumariyeh K, Lenhard D, Schaefer HE, Reinacher PC, Bartsch I, Pantic M, Vinnakota JM, Kakkassery V, Schorb E, Scherer F, Frey AV, Boerries M, Illerhaus G, Duyster J, Schueler J, von Bubnoff N.
Neuropathol Appl Neurobiol. 2023 Apr;49(2):e12899. doi: 10.1111/nan.12899.
Pathophysiology of retinal lymphoma.
Coupland SE, Chan CC, Smith J.
Ocul Immunol Inflamm. 2009 Jul-Aug;17(4):227-37. doi: 10.1080/09273940903168696.
Recurrence of Intraretinal Infiltration of Vitreoretinal Lymphoma.
Gu J, Zhang K, Chang Q.
Ophthalmol Retina. 2023 Nov;7(11):998. doi: 10.1016/j.oret.2023.06.015. Epub 2023 Jul 18.
ASSOCIATION OF VITREORETINAL LYMPHOMA WITH SYSTEMIC LYMPHOMA.
Mashayekhi A, Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Shields CL, Shields JA.
Retina. 2021 Feb 1;41(2):259-265. doi: 10.1097/IAE.0000000000002855.
Ocular Therapy of Vitreoretinal Lymphoma: Local Therapy Has Palliative Effect.
Singh AD.
Ophthalmol Retina. 2024 Apr;8(4):315-316. doi: 10.1016/j.oret.2024.01.024.
Primary Vitreoretinal Lymphoma: Management of Isolated Ocular Disease.
Witmer MT.
Cancer Control. 2016 Apr;23(2):110-6. doi: 10.1177/107327481602300204.
A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
Menean M, Giuffrè C, Cicinelli MV, Marchese A, Modorati G, Bandello F, Miserocchi E.
Eur J Ophthalmol. 2024 Jul;34(4):931-940. doi: 10.1177/11206721231211931. Epub 2023 Nov 13.
Intraocular lymphoma.
Chan CC, Buggage RR, Nussenblatt RB.
Curr Opin Ophthalmol. 2002 Dec;13(6):411-8. doi: 10.1097/00055735-200212000-00012.
